{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent advances in biomarker research have emphasized the utility of epigenetic modifications in disease diagnosis, exemplified by studies in esophageal squamous cell carcinoma where DNA methylation patterns are being explored as precise diagnostic tools."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Although this line of inquiry has not yet extended to ZNF542P directly in the context of cancer, it underscores the broader search for novel molecular markers in complex diseases.\n \nIn parallel, investigations into the mechanisms underlying variable responses to statin therapy have uncovered an intriguing role for zinc finger protein 542 pseudogene (ZNF542P), a noncoding RNA. In experiments involving simvastatin-treated lymphoblastoid and human hepatoma cell lines, ZNF542P emerged as one of the most differentially regulated genes—with its expression changes showing a strong correlation with statin-induced alterations in cellular cholesterol ester levels. Moreover, targeted knock-down of ZNF542P led to increased intracellular cholesterol ester accumulation upon simvastatin treatment, suggesting that this pseudogene may play a functional role in modulating low-density lipoprotein cholesterol response to statins."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Weilin Pu, Chenji Wang, Sidi Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Epigenetics (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13148-017-0430-7"}], "href": "https://doi.org/10.1186/s13148-017-0430-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29270239"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29270239"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kyungpil Kim, Elizabeth Theusch, Yu-Lin Kuang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZNF542P is a pseudogene associated with LDL response to simvastatin treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-30859-y"}], "href": "https://doi.org/10.1038/s41598-018-30859-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30127457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30127457"}]}]}]}